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Bone fragility and associated fracture risk are major problems in aging. Oxidative stress and mitochondrial dysfunction play a key
role in the development of bone fragility. Mitochondrial dysfunction is closely associated with excessive production of reactive
oxygen species (ROS). L-Carnitine (L-C), a fundamental cofactor in lipid metabolism, has an important antioxidant property.
Several studies have shown how L-C enhances osteoblastic proliferation and activity. In the current study, we investigated the
potential effects of L-C on mitochondrial activity, ROS production, and gene expression involved in osteoblastic differentiation
using osteoblast-like cells (hOBs) derived from elderly patients. The effect of 5mM L-C treatment on mitochondrial activity and
L-C antioxidant activity was studied by ROS production evaluation and cell-based antioxidant activity assay. The possible effects
of L-C on hOBs differentiation were assessed by analyzing gene and protein expression by Real Time PCR and western blotting,
respectively. L-C enhanced mitochondrial activity and improved antioxidant defense of hOBs. Furthermore, L-C increased the
phosphorylation of Ca2+/calmodulin-dependent protein kinase II. Additionally, L-C induced the phosphorylation of ERK1/2 and
AKT and the main kinases involved in osteoblastic differentiation and upregulated the expression of osteogenic related genes,
RUNX2, osterix (OSX), bone sialoprotein (BSP), and osteopontin (OPN) as well as OPN protein synthesis, suggesting that L-C
exerts a positive modulation of key osteogenic factors. In conclusion, L-C supplementation could represent a possible adjuvant in
the treatment of bone fragility, counteracting oxidative phenomena and promoting bone quality maintenance.
1. Introduction
Bone participates in mineral homeostasis and fulfills its
biomechanical functions through the process of bone remod-
eling. During aging, the remodeling process is no longer
balanced and a decline in bone-forming cells compared to
bone-resorbing cells activity occurs, leading to bone mass
loss and quality deterioration. Several pathogenic mecha-
nisms contribute to these age-related bone features, but the
decreased differentiation of mesenchymal stem cells into
osteoblasts and/or the senescence of the mature osteoblasts
is considered as major contributors [1–3].
Many studies recognize the key role of mitochondria
activity in ensuring the efficiency of cellular metabolic
functions such as adenosine triphosphate (ATP) production
via oxidative phosphorylation and electron transport chain
(ETC), calcium homeostasis, reactive oxygen species (ROS)
generation, and cellular apoptosis regulation [4, 5]. Since
bone remodeling, in particular osteoblast differentiation,
requires great amount of energy, efficient mitochondria are
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vital for bone formation and bone mass maintenance. In
fact, during osteoblast differentiation, strong mitochondrial
biogenesis was observed, accompanied by increased ATP
production as well as decreased mitochondrial stress [6].
Mitochondrial key role in aging is linked to their essential
contribution in the production and control of ROS levels. At
low concentrations, ROS act as signal regulating numerous
cellular functions: nuclear transcription activity, cell redox
maintenance, cell growth, and differentiation [7, 8]. Nev-
ertheless, the excessive increase of ROS can cause DNA
damage and mitochondrial dysfunction contributing to the
development of various pathological conditions [9]. In fact,
oxidative stress has been associated with osteoblast damage
and bone diseases in aging [6, 10].
Recent interest has been developed on nutraceuticals
for their possibility to modulate osteoblast activity and
oxidative phenomena. L-carnitine (L-C), a cofactor in the 𝛽-
oxidation of fatty acids and a shuttle for the acetyl groups
through the mitochondrial membrane [11], has been shown
to stimulate human osteoblast functions [12] and intracellular
calcium signaling [13]. In particular, L-C, increasing the
performance of mitochondria [14], might provide positive
outcome in high-energy demanding organs, such as muscle
and bone. Noteworthy, L-C displays a direct effect on human
osteoblast by significantly increasing osteoblast activity and
proliferation, as well as the expression of collagen type I, bone
sialoproteins (BSPs), and osteopontin (OPN) [12, 14].
Lately, L-C was shown to have antioxidant activity coun-
teracting age-associated mitochondrial dysfunction in rats
[15, 16] and to keep the balance of mitochondrial produc-
tion of ROS in different type of cells [17, 18]. Recently,
we demonstrated L-C ability to prevent oxidative stress, to
counteract mitochondrial dysfunction and to accelerate the
differentiation of C2C12 myoblasts by inducing myotubes
formation and hypertrophy [19].
We performed the following study with the aim to
characterize the effect of L-C in human trabecular bone
derived osteoblasts (hOB). We evaluated L-C potential in
modulating the balance between mitochondrial-mediated
ROS production and catabolism. We investigated also L-C
potential effect in modulating the downstream signaling of
Ca2+ and in stimulating the expression of osteogenic genes.
Given the interest on nutraceuticals as possible adjuvants in
the current therapies for osteoporosis, this study could help
in characterizing the molecular mechanisms underlying L-C
positive effects on bone cells, thus supporting L-C beneficial
effects in the treatment of bone fragility in the elderly.
2. Materials & Methods
2.1. Materials. All reagents and media were purchased from
Sigma Chemical Co. (St. Louis-MO, USA). Primary antibod-
ies against Calnexin (H-70), GAPDH (FL-335), AKT (C-20),
CaMKII (M-176), pCaMKII𝛼 (Thr286), ERK1 (K-23), ERK2
(C-14), pERK1/2 (E-4), OPN (K-20), and SOD2 (FL-222)
were purchased from Santa Cruz Biotechnology (Heidelberg,
Germany). Primary antibody against Phospho-AKT (Ser473-
D9E-XP) was purchased from Cell Signaling Technology
(Danvers-MA, USA). Peroxidase-conjugated secondary anti-
bodies for Western blot analysis and FITC- or Rhodamine-
conjugated antibodies for immunofluorescence study were
purchased from Santa Cruz Biotechnology (Heidelberg, Ger-
many). Fluorescently-labeled Phalloidin (AlexaFluor488-
Invitrogen) was purchased from Life Technologies (Carlsbad,
CA, USA). CytoPainter Mitochondrial Staining Kit–Green
(AB 112143) was purchased from Prodotti Gianni (Milano,
Italy), and Cell ROXOxidative Stress Reagents Kit (C10443)
was purchased fromThermo Fisher Scientific, Life Technolo-
gies Italia (Monza, Italy).
2.2. HumanOsteoblast-Like Cells (hOBs) Cultures. According
to a modified version of the Gehron-Robey & Termine
procedure [20], human osteoblast cultures were obtained
from waste material of female patients during orthopedic
surgery for degenerative diseases or traumatic fractures of
the femoral neck requiring osteotomy. The protocol was
approved by the Institutional Ethical Committee (Protocol
BMU-WNT, 25.03.2008) and the patients (aged 71–82yr)
signed the informed consent for the use of the waste material.
None of them was affected by any malignant bone diseases.
The effects studied were not affected by the age of the
donors. Briefly, the trabecular bone was cut into small pieces,
rinsed, and incubated with rotation at 37∘C for 30 min with
0.5 mg/ml type IV collagenase. The bone pieces were then
placed in 25cm2 flasks and cultured in Iscove’s modified
medium (IMDM) containing 10% FBS, 100 U/ml penicillin,
100 𝜇g/ml streptomycin, 50 U/ml mycostatin, and 0.25𝜇g/ml
amphotericin B until confluence. Cells were used at first
passage to reduce the possibility of phenotype changes.
2.3. Reverse Transcription and Semiquantitative Real TimePCR.
After 24h of serum starvation, hObs were treated for different
times (1, 3, and 6h) with L-C (5mM). Total RNA from
confluent hOBs was extracted using TRIzol reagent (Thermo
Fisher Scientific Inc., Waltham, MA USA), according to
the manufacturer’s instructions. One 𝜇g of total RNA was
reverse transcribed to cDNA using oligodT primers and M-
MLV reverse transcriptase (Promega Corporation, Madison,
WI, USA). mRNAs expression of osteogenic genes RUNX2,
osterix (OSX), bone-sialo protein (BSP), osteopontin (OPN),
and osteocalcin (BGP)was evaluated byReal TimePCRusing
primer-probe sets validated and purchased as “Assay-on-
Demand” fromApplied Biosystems (ThermoFisher Scientific
Inc., Waltham, MA USA) in singleplex PCR mix. Real
time PCR reaction was performed in an ABI PRISM 7900
Sequence Detection System (Thermo Fisher Scientific Inc.,
Waltham,MAUSA).Gene expressionwas calculatedwith the
2−ΔΔCt method and 𝛽-actin was used as housekeeping gene.
Each experimental point was analyzed in three replicates
and experiments were performed several times with cells
obtained from different donors.
2.4. Western Blot Analysis. After 24 h of serum free culture,
confluent hObs were stimulated with L-C (5 mM) for 5, 15,
and 60 min and for 6h and 24h. Afterwards, hOBs cells
were lysedwithRIPAbuffer supplementedwith proteases and
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phosphatases inhibitors. Equal amounts (35 𝜇g) of protein,
quantified usingThermo Scientific Pierce BCA Protein Assay
Kit (Thermo Fisher Scientific, Milan, Italy), were separated
on SDS-PAGE and transferred to nitrocellulose membrane
(Amersham Protran, Sigma Chemical Co., St. Louis-MO,
USA). Immunoblots were performed as described previously
[21]. Immunoreactive bands were detected by ECL system
according to the manufacturer’s protocol (Amersham Phar-
macia Biotech, Piscataway, NJ, USA). Calnexin or GAPDH
bands were used as loading controls. Scion Image software
(Scion Corp., Frederick, MD, USA) was used to analyze
and quantify bands on X-ray films. The results were then
converted to fold change (FC) of the control.
2.5. Immunoﬂuorescence Analysis. After having starved hObs
for 24h, cells were treated for 3, 6, and 24 h with L-C (5
mM). hObs, fixed and permeabilized, were incubated in PBS
with 1% BSA to avoid nonspecific binding of the antibody.
Cells were then incubated with specific antibodies FITC or
rhodamine conjugated, and nuclei were revealed with DAPI
staining. The MITO CytoPainter mitochondrial indicator
is a hydrophobic compound that easily permeates intact
live cells and becomes trapped in mitochondria. Cell ROX
Oxidative Stress Reagents are fluorogenic probes designed
to measure reactive oxygen species (ROS) in living cells
that exhibit a strong fluorogenic signal during oxidation.
Cells were analyzed using Nikon Eclipse 50I microscopy
with Nis-Elements D 4.00 software (Nikon Instruments
Europe BV, Netherlands). Quantification of immunofluo-
rescence signal was performed by using Image J program
(http://imagej.nih.gov/ij/).
2.6. Cell-Based Antioxidant Activity (CAA) Assay. The
antioxidant activity of L-C in hOBs was evaluated with the
cell-based antioxidant activity (CAA) assay [22]. This cell-
based assay uses the fluorescent probe 2’,7’-dichlorofluorescin
diacetate (DCFH-DA) to determine the radical scavenging
activity of a compound. DCFH-DA 60 𝜇M in HBSS
solution (containing 10 mM Hepes) was added for 20 min
to fully confluent cells in a 96 wells plate. At the end of
incubation, 5 mM L-C or 5 mM L-C + 500 𝜇M 2,2’-azobis(2-
methylpropionamide) dihydro-chloride (AAPH), an oxidant
able to generate peroxyl radicals, was added to cells and the
fluorescence emission at 538 nm (excitation at 485 nm) was
continuously recorded for 120 min (10 min time points) by a
plate reader (Wallac Victor2 1420 Multilabel Counter plate
reader (Perkin Elmer, Beaconsfield, UK). Further samples
in the cell plate were control (CRT), CRT + AAPH, CRT +
L-glutathione (GLUT), and GLUT + AAPH samples. CRT
represented cells incubated only with DCFH-DA; CRT +
AAPH cells incubated with DCFH-DA and 500 𝜇M AAPH;
CRT + GLUT cells treated with DCFH-DA and 750 𝜇M
GLUT; GLUT + AAPH cells treated with DCFH-DA, 750
𝜇MGLUT, and 500 𝜇MAAPH.
The CAA value was calculated for each condition as
follows:
CAA unit = 100 − (∫ SA  ∫CA) × 100
where ∫ SA is the integrated area under the sample
fluorescence versus time curve and ∫CA is the integrated
area of the CRT curve, after subtracting the background value
from the fluorescence readings. Positive CAA values indicate
antioxidant activity vs CRT (CAA value of 0), while negative
CAA values indicate oxidant activity vs CRT.
2.7. Statistical Analysis. Results are shown as the mean ± SD
or ± SEM. Statistical analysis were performed with Prism v
7.00 (GraphPad Software, San Diego, CA, USA) and SPSS
20 (Chicago, IL, USA). Statistically significant differences
were determined using either Student’s t test or ANOVA
tests (Kruskal–Wallis test, two-ways ANOVA) followed by
appropriate multiple-comparison test: Dunn’s post test, or
Bonferroni post hoc t-test. Results were considered signifi-
cant when P ≤ 0.05.
3. Results
3.1. hOBs Mitochondrial Response to L-Carnitine Stimuli.
In order to evaluate L-C effects on mitochondrial activity,
hOBs were treated with L-C (5mM) for 24h, 48h, and 72h.
CytoPainter Mitochondrial Staining Assay showed that L-
C increased the intensity of the signal associated to active
mitochondria after 24, 48 and 72h of treatment compared to
controls, reaching significance (p<0.05) after 72h (Figure 1).
The capacity of L-C to modulate mitochondrial activity in
hOBs suggests that L-C could support the antioxidant activity
of osteoblasts.
3.2. L-Carnitine Decreases Oxidative Stress and Increases
Antioxidative Defense in hOBs. To evaluate the response of
hOBs to oxidative stress, the cells were exposed to 500 𝜇M
H202 and L-C treatment for 6h. L-C induced a decrease in
the mitochondrial production of ROS, compared to controls.
Considering that the observed decrease in ROS production
did not reach a statistical significance (Figure 2(a)), to
evaluate the possible antioxidant activity of L-C in hOBs,
we performed a cell based antioxidant assay (CAA). The
results showed a statistically significant antioxidant effect
of L-C compared to the controls (CAA value = 97 ± 3,
p<0.01).Moreover, when the oxidantmolecules 2,2’-azobis(2-
methylpropionamide) dihydro-chloride (AAPH, 500 𝜇M)
was added together with L-C, the antioxidant activity of L-
C was still detectable, thus indicating its antagonistic effect
towards the oxidative stress induced by AAPH (CAA value
= 87 ± 3; p<0.01). Glutathione (GLUT), a well-characterized
antioxidant compound, was used as a positive control. GLUT
demonstrated a significant antioxidant activity both alone
(CAA value of + 81 ± 7, P< 0.01) and in the presence of AAPH
(CAA value of + 50 ± 10, p<0.01) (Figure 2(b)) comparable
with the effect observed with L-C.
Furthermore, considering the pivotal role of superoxide
dismutase 2 (SOD2) in limiting ROS production in oxidative
stress conditions in mitochondria, we evaluated the effect of
L-C on SOD2. L-C induced a significant increase in SOD2
protein content after 6h and 24h treatment compared to
controls (p<0,001, Figure 2(c)).
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Figure 1: hOBsmitochondrial response to L-Carnitine (L-C) treatment.After 24, 48, and 72h of treatment, the CytoPainterMitochondrial
fluorescence signal associatedwith active mitochondria was increased in L-C-treated hOBs compared to controls (ctrl), reaching significance
at 72h. Mito signal (green), nuclei (DAPI).The quantified signal was normalized for the total nuclei number (magnification: 20X for 24h and
48h; 40X for 72h). Data are themean± SDof six experiments performedwith cells obtained fromdifferent donors. ANOVA for nonparametric
data (Kruskal–Wallis) with Dunn’s multiple comparison test: ∗p < 0.05 vs control (ctrl).
3.3. L-Carnitine Action on Intracellular Calcium Pathway.
Considering that our group recently showed that L-C modu-
lates calcium signaling in hOBs [13], we analyzed the effect
of L-C on the downstream signaling of Ca2+, by inves-
tigating the activation of the calcium-dependent enzyme
Ca2+/calmodulin-dependent protein kinase II (CaMKII). L-
C was able to significantly increase the phosphorylation of
CaMKII𝛼 after 5min and 15 min of treatment (p<0.05). After
60 min the effect on CaMKII𝛼 phosphorylation returned
to the levels of untreated cells (Figure 3(a)). Moreover,
immunofluorescence staining showed that L-C significantly
increased the protein content of total CaMKII after 6h
(p<0.05) compared to controls. The increase was still present
after 24h, but not statistically significant, probably due to the
variability of the data (Figure 3(b)).
3.4. L-Carnitine Eﬀect on Intracellular Signaling in hOBs.
As Ca2+ and calmodulin induce the activation of MAPK
signalling in mammalian cells [23], we investigated the
activation of both ERK andAKT after L-C treatment in hOBs.
L-C induced a significant increase in the phosphorylation
of both ERK1 (p<0.05) and ERK2 (p<0.01) after 15 min
of treatment compared to controls, as shown by the ratios
of pERK1/ERK1 and pERK2/ERK2 reported in Figure 4(a).
Similarly, L-C significantly increased the phosphorylation of
AKT after 5 min (p<0.001) and 15 min (p<0.01) of treatment
compared to controls (Figure 4(b)).
Considering that ERK and AKT have a pivotal role in the
osteogenic lineage differentiation, their activation suggests a
possible involvement of L-C in hOBs differentiation and leads
us to investigate the possible modulation of key osteogenic
factors after L-C treatment.
3.5. L-Carnitine Eﬀect on the Expression of Osteogenic
Related Genes. L-C treatment stimulated mRNA expression
of RUNX2 and OSX, two main transcription factors that
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Figure 2: L-Carnitine (L-C) decreases oxidative stress and increases anti oxidative defense in hOBs. (a): hOBs treated with or without 5
mM L-C for 6h were incubated in oxidative condition (500 mM H202) with Cell ROX Orange Reagent. L-C induced a decrease, although
not significant, in ROS fluorescence signal. ROS signal (red), nuclei (DAPI), and merge (magnification: 20X). The quantified signal was
normalized for the total nuclei number. (b): 5mM L-C treatment was able to enhance antioxidant hOBs capacity even in presence of the pro-
oxidant agent AAPH. Glutathione was used as antioxidant activity control (CAA assay: Each bar reported the CAA values vs untreated cells,
represented by the 0 line; see materials andmethods; ∗p <0.01, two-way ANOVAwith Bonferroni post-test). (c): RepresentativeWestern blot
and relevant quantification of SOD2 protein: after 6 and 24h, L-C induced a significant rise of SOD2 protein content. Data are the mean ± SD
of six experiments performed with cells obtained from different donors. For Western blot and Immunofluorescence studies: Student’s t test:
∗∗∗p <0.001 vs control (ctrl).
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Figure 3: L-Carnitine (L-C) effect on intracellular calcium pathway. (a): Representative Western blot and relevant quantification of
CaMKII𝛼 phosphorylation in hOBs treated with 5 mM L-C. CaMKII𝛼 activation was observed at 5 and 15 min. (b): Immunofluorescence
assay and quantification of total CaMKII protein after 6 and 24h. L-C enhanced the protein content of total CaMKII compared to controls
after 6h. CaMKII (red), nuclei (DAPI), and merge. The quantified signal was normalized for the total nuclei number (magnification: 40X).
Data are the mean ± SD of six experiments performed with cells obtained from different donors. For immunofluorescence andWestern blot
analyses: Student’s t test: ∗p <0.05 vs control (ctrl).
modulate the synthesis of osteoblast specific proteins. L-C
induced a significant increase of RUNX2 at 1h (p<0.05) and
3h (p<0.01) and of OSX at 3h and 6h of treatment (p<0.001,
Figures 5(a) and 5(b)). Three and 6h L-C treatments were
also able to significantly stimulate BSP (p<0.01, p<0.001),
BGP (p<0.01, p<0.05), and OPN (p<0.01, p<0.001) mRNA
expression compared to controls (Figures 5(c), 5(d), and
5(e)). Immunofluorescence staining andWestern blot showed
that OPN protein was increased after 6h (p<0.05) and 24h
(p<0.001) after L-C treatment as well (Figure 6).
3.6. ERK Involvement in the Increased Expression of Osteogenic
Related Genes aer L-Carnitine Treatment. In order to inves-
tigate the role of ERK signaling in the observed increase in
osteogenic genes expression after L-C treatment, we used
FR180204, a selective inhibitor of the kinase activity of ERK1
and ERK2 [24]. Pretreatment with 10𝜇M FR180204 30 min
before 5mM L-C prevented the increase in RUNX2 and OPN
expression by L-C (Figure 7), suggesting that ERKs signaling
is involved in L-C induced increase in the expression of the
osteogenic genes.
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Figure 4: L-Carnitine (L-C) effect on intracellular signaling inhOBs. (a):RepresentativeWestern blot of ERKs andAKT activation in hOBs
after 5 and 15 min of treatment with 5 mM L-C. (b): Relevant quantification of ERK1/2 and AKT phosphorylation. L-C induced a significant
phosphorylation of ERK1/2 at 15 min and of AKT at 5 and 15 min. Data are the mean ± SD of six experiments performed with cells obtained
from different donors. Student’s t test: ∗p <0.05, ∗∗p <0.01,and ∗∗∗p <0.001 vs control (ctrl).
4. Discussion
In this study, we showed that L-C enhances the overall
performance of the mitochondria and protects against oxida-
tive stress. Moreover, L-C activates CaMKII and ERKs/AKT
signaling cascade thus favouring the expression of osteogenic
genes.
Mitochondria have major roles in biological processes
ranging from cellular oxygen sensing to the regulation of
calcium levels [25]. The age related structural deterioration
of bone, due to a dysregulation of bone remodelling, could
be ascribed, at least in part, to reduced energy supply for
altered mitochondria biogenesis and activity [6]. Our study,
showing that L-C enhances the overall performance of the
mitochondria, suggests that L-C could support the fulfillment
of the high metabolic demand of osteoblasts during bone
formation.
A defect in the control of mitochondrial ROS concentra-
tion generates an imbalance between the production and the
degradation of superoxide radicals [26], which exceeds the
osteoblasts detoxification capacity, and inhibits the expres-
sion of osteogenic genes and matrix mineralization [27].
The L-C capacity to increase the mitochondrial production
of SOD2 and to decrease osteoblast ROS content, here
shown, suggests that the mitochondrial-mediated balance
between ROS production and catabolism is improved by L-
C treatment. In fact, to prevent damages due to an accu-
mulation of ROS, mitochondria dismutate unstable super-
oxide anions into the more stable products O2 and H2O2
through the activity of SOD2 activity. SOD2 is the main
mitochondrial antioxidant defense and plays a pivotal role
during osteoblast differentiation as well. SOD2 deficiency
generates an osteoblast dysfunction, whereas its overex-
pression enhances the differentiation of primary osteoblasts
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Figure 5: L-Carnitine (L-C) increased the expression of osteogenic-related genes and of matrix proteins genes. L-C (5mM) stimulated
significantly the gene expression of RUNX2 (a) at 1 and 3h and of OSX (b), BSP (c), BGP (d) and OPN (e) at 3 and 6h compared to control
(straight line). Data are the mean ± SEM of six to nine experiments performed with cells obtained from different donors. ANOVA for
nonparametric data (Kruskal–Wallis) with Dunn’s multiple comparison test: ∗p <0.05, ∗∗p <0.01, and ∗∗∗p <0.001 vs control.
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Figure 6: L-Carnitine (L-C) effect on OPN protein. (a): Immunofluorescence staining of OPN protein after 6h of 5 mM L-C treatment
and relevant quantification showed an increase in OPN protein level compared to control (ctrl). Osteoblastic morphology was analyzed by
Phalloidin (red) and OPN (green) staining. The quantified signal was normalized for the total nuclei number (magnification: 20X). (b):
RepresentativeWestern blot and relevant quantification of OPN protein content increased after 24h of 5 mM L-C stimuli. Data are the mean
± SD of six to nine experiments performed with cells obtained from different donors. Student’s t test: ∗p <0.05, ∗∗∗p <0.001 vs control (ctrl).
derived from SIRT3-deficient mice, which are characterized
by impaired mitochondrial homeostasis and increased mito-
chondrial ROS [6]. Considering that reducing the intracellu-
lar ROS levels is the primary defense against the cell injury
induced by oxidative stress, we can speculate that L-C could
potentially counteract the excessive ROS accumulation that
favors the altered osteoblast metabolism during aging. In
addition, SOD2 capacity to reduce ROS levels is able to inhibit
the osteoclasts differentiation process, in which ROS play a
role as second messenger [28].
In the present study, we also showed that L-C acti-
vates CaMKII and ERKs/AKT signaling cascade to induce
osteogenic gene expression. CaMKII is an ubiquitous protein.
The CaMKII 𝛼 isoform is mainly expressed in osteoblasts
10 BioMed Research International
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Figure 7: Effect of the inhibition of ERKs signaling on L-
Carnitine (L-C) induced gene expression.The increase inOSX and
OPN mRNA expression 3h after L-C was prevented by pretreating
hOBs 30 min before L-C with 10𝜇M FR180204, an inhibitor of
ERKs activity. ANOVA for nonparametric data (Kruskal–Wallis)
withDunn’smultiple comparison test: ∗p <0.05, ∗∗p <0.01 vs control
(ctrl); eeep <0.001 vs L-C.
and has a role in their differentiation [29]. In mammalian
cells, CaMKII signaling induces the activation of MAP
kinases [23], such as ERKs and AKT. These two pathways
are essential for osteoblast growth and differentiation [30]
and are involved in the modulation of integrin levels at cell
surface, thus contributing to cell adhesion [31]. Moreover,
ERKs increase the expression of RUNX2 [32], the main
transcription factor of osteoblasts differentiation, thus reg-
ulating the deposition of bone matrix proteins [33]. Our
results showing that L-C upregulates both RUNX2 and
OSX gene expressions, via ERK pathway, support a role
of L-C in favoring osteogenic cell functions. Noteworthy,
L-C also activates AKT, a serine/threonine kinase present
in all cells that, when activated, mediates downstream
responses, including cell survival, growth, and proliferation
by phosphorylating a range of intracellular proteins. When
activated in osteoblast, AKT enhances osteoblast differen-
tiation by promoting RUNX2 protein stability [34]. It is
therefore likely that AKT activation by L-C might con-
tribute to the observed positive effect of the compound on
osteogenesis.
Finally, L-C stimulates the expression of noncollagenous
proteins such as BSP, BGP, and OPN. In particular, BSP
is involved in the regulation of hydroxyapatite crystal for-
mation. BSP-/- mice display impaired mineralization and
endochondral bone development [35]. BGP is specifically
produced by osteoblasts and, besides its endocrine role [36],
it is a marker of mature osteoblast. OPN influences the
mechanical properties of bone. OPN-/- mice are character-
ized by reduced bone strength, although their overall bone
phenotype is normal [37]. Given the critical role of these
noncollagenous proteins in determining bone mineraliza-
tion, elasticity, and strength [38], we can speculate that their
induction in hOBs by L-C might have a beneficial effect on
the osteoporotic bone. In osteoporotic condition, noncol-
lagenous proteins are indeed modified and their amount is
reduced with aging, thus affecting mechanical competence
[39]. This hypothesis is further supported by the evidence
that L-C and its derivatives, by accelerating the recovery of
normal BV/TV, have a beneficial effect on trabecular bone in
a hypocalcemic diet-induced mouse model of osteoporosis.
[40].
5. Conclusions
In conclusion, we showed that, in hOBs, L-C improves
mitochondrial antioxidant activity and stimulates several
signaling pathways involved in osteogenesis. Our study, by
further characterizing L-C effects in osteoblasts (summarized
in Figure 8), suggest a role for L-C as a potential candi-
date in counteracting the decline of bone mass in skeletal
senescence.
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